completely new strength [Regulatives / Guidelines]

posted by jag009  – NJ, 2013-10-21 19:53 (4628 d 08:28 ago) – Posting: # 11722
Views: 4,219

Hi,

❝ Since there is already a publicated study in this regard, performed on ​​the original product, do You think is it possible to skip the absolute-BA or/and the food effect, or there is a need to perform all three of them?

❝ Would it make sense to think about performing a dose proportionality test between the 70 mg test and the 100 mg reference, or would it make sense to develop a 100 mg test, perform a bioequivalence trial for the 100 mg strength, and after this bioequivalence is demonstrated, the 35 mg and 70 mg strength to be submitted, based on a dose proportionality studty???


That's a bit monumental for developing a "middle" strength(s) generic of a product, don't you think? This might be out of line but what is the benefit of 35 and 70 mg strengths of your client's product?

John

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
139 visitors (0 registered, 139 guests [including 40 identified bots]).
Forum time: 04:21 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5